Elevance Health ELV Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 89.4%+0.5pp | 88.8%-1.1pp | 89.9%-1.8pp | 91.7%-0.5pp | |
| Net margin | 2.8%-0.5pp | 3.4%-0.1pp | 3.5%-0.3pp | 3.8%-0.7pp | |
| Free cash flow margin | 1.7%-0.9pp | 2.6%— | —— | —— | |
| Returns | |||||
| Return on equity | 13.3%-1.5pp | 14.8%-1.0pp | 15.8%-0.4pp | 16.3%-1.5pp | |
| Return on assets | 4.8%-0.5pp | 5.3%-0.4pp | 5.7%-0.2pp | 5.9%-0.8pp | |
| Efficiency | |||||
| Asset turnover | 1.7×+0.1× | 1.6×-0.1× | 1.6×+0.1× | 1.6×+0.1× | |
| Liquidity | |||||
| Current ratio | 1.5×+0.1× | 1.5×0.0× | 1.4×0.0× | 1.4×-0.1× | |
| Quick ratio | 1.5×+0.1× | 1.5×0.0× | 1.4×0.0× | 1.4×-0.1× | |
| Cash ratio | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0.7×0.0× | 0.7×+0.1× | 0.6×0.0× | 0.6×0.0× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Valuation | |||||
| Market capitalization | $77.91B-8.9% | $85.56B-22.2% | $109.91B-10.0% | $122.07B+9.1% | |
| Enterprise value | $100.02B-7.1% | $107.66B-15.7% | $127.7B-7.6% | $138.22B+6.8% | |
| Price / earnings | 13.8×-0.5× | 14.3×-4.1× | 18.4×-2.4× | 20.7×+2.5× | |
| Price / sales | 0.4×-0.1× | 0.5×-0.2× | 0.6×-0.1× | 0.8×0.0× | |
| Price / book | 1.8×-0.3× | 2.1×-0.7× | 2.8×-0.6× | 3.4×+0.3× | |
| EV / sales | 0.5×-0.1× | 0.6×-0.1× | 0.7×-0.1× | 0.9×-0.1× | |
| Free cash flow yield | 4.3%-1.0pp | 5.3%— | —— | —— | |
| Earnings yield | 7.3%+0.3pp | 7%+1.5pp | 5.4%+0.6pp | 4.8%-0.7pp | |
| Dividend yield | 2%+0.2pp | 1.8%+0.5pp | 1.3%+0.3pp | 1%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Elevance Health's ratios come from?
- Every ratio is computed from Elevance Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
